Nippon India Pharma Fund(IDCW)

How to use scorecard? Learn more

IDCW

EquitySectoral Fund - Pharma & Health Care

Large-size FundAssets Under Mgmt: ₹ 8,688 Cr

Very High RiskPrinciple investment will be at very high risk

183.130.54% (+0.98)

How to use scorecard? Learn more

EquitySectoral Fund - Pharma & Health Care

Large-size FundAssets Under Mgmt: ₹ 8,688 Cr

Very High RiskPrinciple investment will be at very high risk

Key Metrics

Expense RatioExpense Ratio	No LabelNo Label	No LabelNo Label
0.91	52.56	2.21

No LabelNo Label	No LabelNo Label	No LabelNo Label
1.47	52.72	2.09

Scheme Info

PlanPlan	Lock inLock in	Exit LoadExit Load
IDCW	0 yrs	1.00% 1% on or before 1M Nil after 1M

SIP Inv.SIP Inv.	Min. LumpsumMin. Lumpsum
Allowed	₹ 5,000 Initial: ₹ 5,000 Incremental: ₹ 1,000

BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Peers & Comparison

Comparing 3 mutual funds from
EquitySectoral Fund - Pharma & Health Care

Returns

Scheme

Ratios

Mutual Fund	1Y Returns1Y Returns	3Y CAGR3Y CAGR	Life CAGRLife CAGR
Nippon India Pharma Fund(IDCW)	26.54%	17.40%	11.97%
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW-Payout)	36.52%	16.36%	16.81%
SBI Healthcare Opp Fund(IDCW-Payout)	43.44%	25.26%	17.33%
DSP Healthcare Fund(IDCW-Reinv)	29.99%	12.63%	20.29%

Price Comparison

Compare Nippon India Pharma Fund(IDCW) with any MF, ETF, stock or index

Nippon India Pharma Fund(IDCW)

Hmm, looks like data is unavailable here. Please come back after some time

AMC Profile

Nippon India Mutual Fund is one of India’s leading mutual funds, with Average Assets Under Management (AAUM) of Rs 2,79,431 Crores. NIMF has been established as a trust under the Indian Trusts Act, 1882 with Nippon Life Insurance Company as its Sponsor and Nippon Life India Trustee Ltd as its Trustee.

No.of Schemes
80
Total AUM
₹ 4,25,180.60 Cr.

Fund Manager Profile

Sailesh Raj Bhan

AUM: ₹83,002.92 Cr.

Exp: 10yrs

Qualification

MBA (Finance), CFA (ICFAI)

Past Experience

Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

Tax Implications

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)

This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

You make

Hmm, looks like data is unavailable here. Please come back after some time.

Nippon India Pharma Fund(IDCW)